We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+11.77%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.8B
AUM Growth
-$40.1M
Cap. Flow
-$460M
Cap. Flow %
-7.92%
Top 10 Hldgs %
24.55%
Holding
197
New
37
Increased
72
Reduced
55
Closed
17

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$46.7M
2
IRTC icon
iRhythm Holdings
IRTC
+$37M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$35.8M
4
ENTG icon
Entegris
ENTG
+$21.4M
5
GLBE icon
Global E Online
GLBE
+$20.4M

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$70.1M
2
TT icon
Trane Technologies
TT
+$69.4M
3
DDOG icon
Datadog
DDOG
+$63.8M
4
ARGX icon
argenx
ARGX
+$56M
5
GTLB icon
GitLab
GTLB
+$46.9M

Sector Composition

Rank Sector Weight
1 Healthcare 40.6%
2 Technology 18.78%
3 Industrials 17.39%
4 Consumer Discretionary 9.97%
5 Financials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
76
Revolution Medicines
RVMD
$40.9B
$23.7M 0.41%
523,051
-127,775
-20% -$5.56M
SO icon
77
Southern Company
SO
$106B
$23.6M 0.41%
261,941
-29,472
-10% -$2.52M
VCYT icon
78
Veracyte
VCYT
$4.77B
$23.1M 0.4%
677,883
+113,883
+20% +$3.2M
CELC icon
79
Celcuity
CELC
$4.27B
$22.9M 0.39%
1,535,000
– –
VRSK icon
80
Verisk Analytics
VRSK
$26.1B
$22.7M 0.39%
84,752
-386
-0.5% -$104K
NOVT icon
81
Novanta
NOVT
$4.95B
$22.6M 0.39%
126,430
+26
+0% +$4.52K
IP icon
82
International Paper
IP
$22.8B
$22.3M 0.39%
457,235
+117,838
+35% +$5.49M
KROS icon
83
Keros Therapeutics
KROS
$202M
$22.1M 0.38%
380,000
-119,208
-24% -$5.89M
RPRX icon
84
Royalty Pharma
RPRX
$26.2B
$21.9M 0.38%
772,623
+22,993
+3% +$637K
INZY
85
DELISTED
Inozyme Pharma
INZY
$21.6M 0.37%
4,134,436
+198,216
+5% +$1.03M
BHVN icon
86
Biohaven
BHVN
$2.08B
$20M 0.34%
399,827
-234,837
-37% -$9.14M
EQR icon
87
Equity Residential
EQR
$25.2B
$19.8M 0.34%
+266,088
New +$19.2M
RCM
88
DELISTED
R1 RCM Inc. Common Stock
RCM
$19.5M 0.34%
1,375,999
+19
+0% +$258
SRRK icon
89
Scholar Rock
SRRK
$5.87B
$19.3M 0.33%
2,409,207
-665,268
-22% -$5.84M
AIT icon
90
Applied Industrial Technologies
AIT
$12.6B
$19.2M 0.33%
85,923
+5,430
+7% +$1.11M
ESI icon
91
Element Solutions
ESI
$8.68B
$19.1M 0.33%
702,168
-99,945
-12% -$2.62M
RLAY icon
92
Relay Therapeutics
RLAY
$4.24B
$19M 0.33%
+2,682,083
New +$20M
BBIO icon
93
BridgeBio Pharma
BBIO
$16.1B
$18.3M 0.31%
716,927
– –
APTV icon
94
Aptiv
APTV
$12.3B
$18.1M 0.31%
251,021
+240
+0.1% +$16.8K
MSCI icon
95
MSCI
MSCI
$41.9B
$18.1M 0.31%
31,001
-2,274
-7% -$1.23M
RGEN icon
96
Repligen
RGEN
$7.03B
$17.7M 0.31%
119,000
– –
KRYS icon
97
Krystal Biotech
KRYS
$10.8B
$17.4M 0.3%
95,781
-40,704
-30% -$7.85M
RNAM
98
DELISTED
Avidity Biosciences
RNAM
$17.3M 0.3%
375,924
– –
TGTX icon
99
TG Therapeutics
TGTX
$8.19B
$16.8M 0.29%
718,814
– –
LXEO icon
100
Lexeo Therapeutics
LXEO
$342M
$16.8M 0.29%
1,855,986
-1,513,161
-45% -$18M
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Eventide Asset Management held 197 positions worth $5.8B, down 0.69% from $5.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $460M in Q3 2024, closing 17 positions and reducing 55 holdings. Its most notable exit was Nextpower Inc, an estimated $36.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Relay Therapeutics worth $19M.

  • Eventide Asset Management's largest Q3 2024 buy was Relay Therapeutics: 2,682,083 shares worth $19M.
  • Eventide Asset Management added most to Verona Pharma in Q3 2024, an estimated $46.7M increase.
  • Eventide Asset Management's biggest Q3 2024 reduction was Transmedics, cutting an estimated $70.1M.
  • Eventide Asset Management fully exited Nextpower Inc in Q3 2024, selling an estimated $36.6M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.8B portfolio in Q3 2024.
  • Eventide Asset Management opened 37 new positions and closed 17 in Q3 2024.
  • Eventide Asset Management's portfolio value fell 0.69% quarter-over-quarter to $5.8B.

Based on Eventide Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.